The ACETYLCYSTEINE SOLUTION is a the manufacturer industrial component. Key specifications include administration: ORAL, features_provided: STERILE, primary_container_type: BOTTLE, pharmaceutical_vehicle_type: ANY ACCEPTABLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 30.000 MILLILITERS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-229-9322, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| features_provided | STERILE |
| primary_container_type | BOTTLE |
| pharmaceutical_vehicle_type | ANY ACCEPTABLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 3 |
| primary_container_content_quantity | 30.000 MILLILITERS |
| active_medicament_medicinal_strength | 10.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT |
| NSN | 6505-00-229-9322 |
| ADMINISTRATION | ORAL |
| TOTAL PRIMARY CONTAINER QUANTITY | 3 |
| PRIMARY CONTAINER TYPE | BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 PERCENTAGE, W/V ACETYLCYSTEINE ACTIVE INGREDIENT |
| FEATURES PROVIDED | STERILE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PHARMACEUTICAL VEHICLE TYPE | ANY ACCEPTABLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |